-
Successful Coronary Interventions with the Aid of Abciximab (ReoPro (R)) in High-Risk Patients: Report of Two Cases
-
Woo Suck Park, Myung Ho Jeong, Nam Ho Kim, Young Keun Ahn, Youl Bae, Gwang Chae Gill, Joo Hyung Park, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang
-
Korean J Crit Care Med. 1998;13(2):254-260.
-
-
-
 Abstract
 PDF
- Abrupt closure of coronary artery during coronary intervention is one of major limitations especially in high-risk patients. Platelets are responsible for composing acute thrombotic occlusion at the site of therapeutic arterial injury. Abciximab (platelet glycoprotein IIb/IIIa receptor blocker) might be helpful in preventing the acute thrombotic occlusion. We experienced an excellent effects of the drug in two cases of high-risk patients, unsuccessful thrombolytics and PTCA with acute occlusion. With additional use of abciximab we overcame the complications and succeeded in getting normal coronary flow and resultant successful angioplasties.
|
KSCCM
